Genomic instability in chronic viral hepatitis and hepatocellular carcinoma

Citation
Mp. Dore et al., Genomic instability in chronic viral hepatitis and hepatocellular carcinoma, HUMAN PATH, 32(7), 2001, pp. 698-703
Citations number
37
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Journal title
HUMAN PATHOLOGY
ISSN journal
00468177 → ACNP
Volume
32
Issue
7
Year of publication
2001
Pages
698 - 703
Database
ISI
SICI code
0046-8177(200107)32:7<698:GIICVH>2.0.ZU;2-W
Abstract
Chronic hepatitis may progress to cirrhosis and hepatocellular carcinoma (H CC). Progressive accumulation of mutations and genomic instability in chron ic viral hepatitis might flag an increased risk of HCC development. Genomic instability at dinucleotide microsatellite loci in chromosomes 2, 13, and 17 and at 2 mononucleotide repeat loci was examined in liver tissues from 4 1 patients, including 30 without HCC (18 patients with chronic hepatitis an d 12 with cirrhosis) and 11 with HCC. Genomic instability was detected in 5 1% of the 41 cases. Allelic imbalance at informative dinucleotide loci occu rred in 37% of the cases. In 14 cases (34%), allelic imbalance was detected in chronic hepatitis or cirrhosis without HCC. Allelic imbalance at the ch romosome 13 locus was detected in 50% of the cases of chronic hepatitis C. Allelic imbalance at the TP53 chromosome locus and/or at the chromosome 13 locus was significantly more frequent than alterations at the chromosome 2 locus (P = .026). Low-level microsatellite instability was found in 20% of all cases examined and high-level microsatellite instability in 3 patients (7.5%), including 2 cases of chronic hepatitis and 1 case of cirrhosis. Our results show that allelic imbalance occurs frequently in hepatitis-related HCC as well as in chronic hepatitis in patients without HCC. Allelic imbal ance at the D13S170 chromosome 13 locus (13q31.2) occurs frequently in chro nic hepatitis, suggesting that genomic alterations affecting the long arm o f chromosome 13 might be used to monitor the natural progression of chronic hepatitis-associated liver carcinogenesis. HUM PATROL 32:698-703. Copyrigh t (C) 2001 by W.B. Saunders Company.